High-dose risedronate treatment partially preserves cancellous bone mass and microarchitecture during long-term disuse
- 30 September 2005
- Vol. 37 (3) , 287-295
- https://doi.org/10.1016/j.bone.2005.04.041
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Long-Term Disuse Osteoporosis Seems Less Sensitive to Bisphosphonate Treatment Than Other OsteoporosisJournal of Bone and Mineral Research, 2005
- Disorders Associated With Acute Rapid and Severe Bone LossJournal of Bone and Mineral Research, 2003
- Long-Term Treatment of Incadronate Disodium Accumulates Microdamage but Improves the Trabecular Bone Microarchitecture in Dog VertebraJournal of Bone and Mineral Research, 2003
- Beneficial Effect of Intermittent Cyclical Etidronate Therapy in Hemiplegic Patients Following an Acute StrokeJournal of Bone and Mineral Research, 2000
- The Effects of Twelve Weeks of Bed Rest on Bone Histology, Biochemical Markers of Bone Turnover, and Calcium Homeostasis in Eleven Normal SubjectsJournal of Bone and Mineral Research, 1998
- Longitudinal Study of Bone Turnover after Acute Spinal Cord InjuryJournal of Clinical Endocrinology & Metabolism, 1998
- The effect of pamidronate in a new model of immobilization in the dogBone, 1995
- Risedronate treatment does not increase microdamage in the canine femoral neckBone, 1995
- Transient effects of subcutaneously administered prostaglandin E2 on cancellous and cortical bone in young adult dogsBone, 1990
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987